Association of salivary levels of immunoglobulin-a and amylase with oral-dental manifestations in patients with controlled and non-controlled type 2 diabetes

被引：0
|
作者：
Marjan Kheirmand Parizi
Hamed Akbari
Mahsa Malek-mohamadi
Maryam Kheirmand Parizi
Shahla Kakoei
机构：
[1] Kerman University of Medical Sciences,Dentist, Student Research Committee, School of Dentistry
[2] Kerman University of Medical Sciences,Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences
[3] Kerman University of Medical Sciences,Department of Biochemistry, School of Medicine
[4] Shahid Beheshti University of Medical Sciences,Community Oral Health Department, School of dentistry
[5] Shahid Beheshti University of Medical Sciences,Student Research Committee
[6] Dental School,Oral and Dental Diseases Research Center
[7] Kerman University of Medical Sciences,Department of Oral Medicine, School of Dentistry
[8] Kerman University of Medical Sciences,undefined
来源：
BMC Oral Health | / 19卷
关键词：
Diabetes mellitus; Saliva; Salivary immunoglobulin-a; Salivary amylase; Oral manifestations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association of Dental Diseases and Oral Hygiene Care With the Risk of Heart Failure in Patients With Type 2 Diabetes: A Nationwide Cohort Study
    Huh, Youn
    Yoo, Jung Eun
    Park, Sang-Hyun
    Han, Kyungdo
    Kim, Seon Mee
    Park, Hye Soon
    Cho, Kyung Hwan
    Ahn, Jin-Soo
    Jun, Sang Ho
    Nam, Ga Eun
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (16):
  • [32] The effects of oral trehalose on glycaemia, inflammation, and quality of life in patients with type 2 diabetes: a pilot randomized controlled trial
    Hashemian, Somayyeh
    Shojaei, Mehrnaz
    Radbakhsh, Shabnam
    Ashari, Sorour
    Riahi, Maryam Matbou
    Amiri, Zeinab Shateri
    Atkin, Stephen L.
    Banach, Maciej
    Bagherniya, Mohammad
    Emami, Seyed Ahmad
    Sahebkar, Amirhossein
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (06) : 1693 - 1700
  • [33] Association between dental caries indicators and serum glycated hemoglobin-levels among patients with type 2 diabetes mellitus
    Majbauddin, Abir
    Tanimura, Chika
    Aoto, Haruka
    Otani, Shinji
    Parrenas, Maria C. E.
    Kobayashi, Nobuyuki
    Morita, Tetsuji
    Inoue, Kazuoki
    Masumoto, Toshio
    Kurozawa, Youichi
    JOURNAL OF ORAL SCIENCE, 2019, 61 (02) : 335 - 342
  • [34] Effect of Aqueous Cinnamon Extract on the Postprandial Glycemia Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
    Rachid, Ana Paula
    Moncada, Margarida
    de Mesquita, Maria Fernanda
    Brito, Jose
    Bernardo, Maria Alexandra
    Silva, Maria Leonor
    NUTRIENTS, 2022, 14 (08)
  • [35] Association of Inadequate Health Literacy with Health Outcomes in Patients with Type 2 Diabetes and Depression: Secondary Analysis of a Controlled Trial
    Al Sayah, Fatima
    Majumdar, Sumit R.
    Johnson, Jeffrey A.
    CANADIAN JOURNAL OF DIABETES, 2015, 39 (04) : 259 - 265
  • [36] Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic Agents
    Kim, Kibum
    Unni, Sudhir
    McAdam-Marx, Carrie
    Thomas, Sheila M.
    Sterling, Kimberly L.
    Olsen, Cody J.
    Johnstone, Bryan
    Mitchell, Matt
    Brixner, Diana
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (03): : 314 - +
  • [37] The add-on effect of SGLT2 inhibitor or thiazolidinedione in patients with type 2 diabetes inadequately controlled with triple oral antidiabetics
    Kim, H.
    Kim, Y. -E.
    Lee, S.
    Bae, J.
    Lee, M.
    Huh, J.
    Lee, B. -W.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S270 - S270
  • [38] Metabolic profile and cardiovascular risk in patients with Type 2 diabetes not controlled with oral antidiabetic agents: Post-Adelante study
    Calderon, A.
    Sarasa, P.
    Barrios, V.
    DIABETIC MEDICINE, 2008, 25
  • [39] Glycemic Control with Preprandial Versus Basal Insulin in Patients with Type 2 Diabetes Mellitus Poorly Controlled by Oral Antidiabetes Agents
    Heise, T.
    Mathieu, C.
    Hey-Hadavi, J.
    Strack, T.
    Lawrence, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (02) : 135 - 141
  • [40] Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial
    Goke, B.
    Gallwitz, B.
    Eriksson, J.
    Hellqvist, A.
    Gause-Nilsson, I.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (12) : 1619 - 1631
12345